Detecting hundreds of the most commonly mutated genes involved in cancer

Detecting hundreds of the most commonly mutated genes involved in cancer

January 23, 2017

How can you survey more than 100 oncogenes and tumor suppressor genes in your cancersamples?

The newly developed Human Comprehensive Cancer Panel allows you to enrich genes and construct libraries for NGS analysis of hundreds of genes most commonly mutated in cancer, covering oncogenes, tumor suppressor genes, genes involved in angiogenesis, apoptosis, DNA damage and repair, epigenetics, immune responses, etc. The system provides you with a complete Sample to Insight solution and a simple, streamlined workflow for routine known and novel cancer mutation detection on any NGS platform from Illumina and Ion Torrent.

 

 

New TP53 MASTR

New TP53 MASTR

Multiplicom is pleased to announce the release of the TP53 MASTR molecular assay for the identification of mutations in the entire coding region of TP53.




September 29, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us